Skip to main content
. 2022 May 23;27(7):e601–e603. doi: 10.1093/oncolo/oyac104

Table 1.

Percent mammographic density and absolute density change at three time points compared with baseline for the 33 women completing at least 6 months of medication, subdivided per dose arm.

Characteristics Month 0 Month 3 Month 6 Month 9
Number of women having a mammogram 33 33 33 33
All women (N = 33)
 Age at baseline, mean (SD) 62.1 (SD 9.1)
 Postmenopausal, % 82
 Mammography density, mean (95% CI) 17.6 (12.3-22.8) 15.8 (11.0-22.5) 15.3 (10.5-20.1) 14.6 (10.3-19.0)
 Absolute density difference, mean (95% CI) Ref. −1.8 (−3.3 to −0.2) −2.2 (−4.2 to −0.3) −2.9 (−5.0 to −0.9)
Women in the 10 mg arm (N = 19)
 Age at baseline, mean (SD) 60.0 (SD 8.9)
 Postmenopausal, % 68
 Mammography density, mean (95% CI) 15.9 (8.9-22.8) 13.7 (7.4-20.0) 12.7 (6.4-19.0) 12.6 (6.8-18.3)
 Absolute density difference, mean (95% CI) Ref. −2.1 (−4.2 to −0.1) −3.1 (−5.7 to −0.5) −3.3 (−6.1 to- −0.5)
Women in the 20 mg arm (N = 14)
 Age at baseline, mean (SD) 65.1 (SD 5.3)
 Postmenopausal, % 100
 Mammographic density, mean (95% CI) 19.9 (11.8-27.9) 18.5 (11.2-25.9) 18.8 (11.5-26.2) 17.4 (10.7-24.1)
 Absolute density difference, mean (95% CI) Ref. −1.3 (−3.7 to -1.1) −1.0 (-4.1-2.0) −2.5 (−5.7 to 0.8)

Abbreviations: CI, confidence interval; SD, standard deviation.